“Since 2023, the state has paid for Medicaid patients’ weight-loss treatment with these drugs, known as GLP-1s. The planned change, which takes effect Jan. 1, will mean they won’t be covered solely for weight loss and obesity.”
Pennsylvania restricts Medicaid coverage for GLP‑1 drugs • Spotlight PA